In April 2026, WHO prequalified a formulation of artemether–lumefantrine specifically designed for infants and three new rapid diagnostic tests. Sanjeet Bagcchi reports.
Source link
In April 2026, WHO prequalified a formulation of artemether–lumefantrine specifically designed for infants and three new rapid diagnostic tests. Sanjeet Bagcchi reports.
Source link